integrated commercialization solutions inc.
Trade trend analysis
Number of Transactions Quantity Weight
Number of Transactions Quantity Weight
The above chart presents the market trend analysis for integrated commercialization solutions inc. from 2017 to 2018. By examining various dimensions such as transaction quantity, transaction weight, average price, and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability. As of 2018, the company has completed 1 transactions, with a transaction quantity of 5 and a transaction weight of 1683.
- Year Transactions Quantity Weight
- 2017 0 0 0
- 2018 1 5 1683
Bill of lading data
< 1/1 >- Trade date 2018/09/19 B/L No. dmalvtz000451
- Suppliers gland pharma ltd. Buyers integrated commercialization solutions inc.
- POLs colombo PODs norfolk
- Supply area Other Purchas area United States
- Weight 1683kg Amount 24408
- Hs code 300490 Product tags sp 100,g20,gml,invoice no ex,iu,9d,e 30,rat,cod,oxaliplatin injection,o2,gh
- Product description OXALIPLATIN INJECTION USP 50MG10ML5MGML OXALIPLATIN INJECTION USP 100MG20ML5MLML HS CODE 30049099 INVOICE NO EXPVSEZII028201819DATE30072018 PO NO2300008 DATE06012018 SB NO400175406082018 NET WEIGHT 1432200 KGS TEMPRATURE22 CELCIUS TOTAL 5 FIVE PACKS ONLY Expand
Partners
Total 1- Rank Company Transactions Per Detail
- 1 gland pharma ltd. indiasupplier,they trade on 2018-09-19 1 100% >
Products
Total 12- Products Transactions Per Detail
-
9d
1 100% > -
cod
1 100% > -
e 30
1 100% > -
g20
1 100% > -
gh
1 100% >
+View All
Hscode rank
Total 1- HSCode Name Transactions Per Detail
- HS 300490 1 100% >
Trading Area
Total 1- Area Transactions Per Detail
- other 1 100% >
Port statistics
Total 1- Port Name Transactions Per Detail
- norfolk 1 100% >